human cord blood progenitor cell exosomes은 임신 중 안전한가요?
No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
Related ingredients
Frequently asked questions
- human cord blood progenitor cell exosomes은 임신 중 안전한가요?
- No harmonised CLP classification, no SCCS/CIR safety assessment specific to 'human cord blood progenitor cell exosomes' and no published evidence of reproductive/teratogenic effects in humans or animals was identified in available regulatory sources. However, because these are biologically active extracellular vesicles carrying proteins/miRNA there is a theoretical mechanism for biological signalling (mechanism score=1). Dermal systemic exposure from topical cosmetics is expected to be low but not zero (exposure score=1) given the potential for vesicle uptake reported in topical exosome literature; no pregnancy-specific data were found.
- human cord blood progenitor cell exosomes은 모유 수유 중 안전한가요?
- No specific regulatory or peer‑reviewed data showing harm via breastmilk or effects on lactation. Theoretical mechanism exists (bioactive cargo could in theory be transferred systemically and into milk), but there is no empirical evidence. Dermal exposure for lactating persons is expected to be low but measurable.
- human cord blood progenitor cell exosomes은 아기 피부에 안전한가요?
- No data demonstrating developmental/infant toxicity from topical use. Mechanistic theoretical concern persists (bioactivity of exosome cargo). Exposure score increased by +1 for infants because immature skin has higher permeability and higher surface‑area‑to‑weight; if adult exposure is low/measurable (1), infant exposure is judged as moderate (2). No infant‑specific absorption or toxicity studies were identified.
- VeriMom은 human cord blood progenitor cell exosomes을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 human cord blood progenitor cell exosomes을 87/100 (낮은 위험)로 평가합니다.
- 임신 중 human cord blood progenitor cell exosomes 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.